Wilson W D, George L W, Baggot J D, Adamson P J, Hietala S K, Mihalyi J E
Am J Vet Res. 1987 Mar;48(3):407-14.
The pharmacokinetics, bioavailability, and distribution to the tears of ormetoprim (OMP; 5.5 mg/kg of body weight) and sulfadimethoxine (SDM; 27.5 mg/kg of body weight) were determined following IV or oral administration to 6 Holstein steers. After IV administration, the disposition kinetics of both drugs were best described by a 2-compartment open model. Sulfadimethoxine had a moderately rapid distribution phase, followed by a slower elimination phase, with a mean half-life (t 1/2) of 7.91 hours. The mean volume of distribution of SDM was 185 ml/kg, and the mean body clearance was 0.28 ml/min X kg. The concentration of SDM in tears was lower than the corresponding plasma concentration, and the elimination of SDM from tears (t 1/2 = 3.02 hours) was significantly faster than its elimination from plasma (t 1/2 = 7.91 hours). The disposition of OMP administered IV was characterized by a rapid distribution phase, followed by a rapid elimination phase (t 1/2 = 1.37 hours). The high values of the mean volume of distribution (1,450 ml/kg) and mean rate of body clearance (13.71 ml/min X kg) indicated that OMP was widely distributed in the body and was rapidly cleared from the body. Ormetoprim concentrations in tears exceeded corresponding plasma concentrations, and the elimination of OMP from tears was significantly slower (t 1/2 = 1.91 hours) than from plasma (t 1/2 = 1.37 hours). After oral administration of an OMP-SDM combination in bolus form, the absorption of SDM was slow (absorption t 1/2 = 3.32 hours), but complete.(ABSTRACT TRUNCATED AT 250 WORDS)
对6头荷斯坦奶牛静脉注射或口服奥美普明(OMP;5.5毫克/千克体重)和磺胺二甲氧嘧啶(SDM;27.5毫克/千克体重)后,测定了它们的药代动力学、生物利用度以及在泪液中的分布情况。静脉注射后,两种药物的处置动力学均可用二室开放模型最佳描述。磺胺二甲氧嘧啶有一个适度快速的分布阶段,随后是一个较慢的消除阶段,平均半衰期(t1/2)为7.91小时。磺胺二甲氧嘧啶的平均分布容积为185毫升/千克,平均机体清除率为0.28毫升/分钟×千克。泪液中磺胺二甲氧嘧啶的浓度低于相应的血浆浓度,且磺胺二甲氧嘧啶从泪液中的消除(t1/2 = 3.02小时)明显快于其从血浆中的消除(t1/2 = 7.91小时)。静脉注射奥美普明的处置特点是分布阶段快速,随后是快速消除阶段(t1/2 = 1.37小时)。平均分布容积(1450毫升/千克)和平均机体清除率(13.71毫升/分钟×千克)的高值表明奥美普明在体内广泛分布且迅速从体内清除。泪液中奥美普明的浓度超过相应的血浆浓度,且奥美普明从泪液中的消除(t1/2 = 1.91小时)明显慢于从血浆中的消除(t1/2 = 1.37小时)。以大剂量形式口服奥美普明 - 磺胺二甲氧嘧啶组合后,磺胺二甲氧嘧啶的吸收缓慢(吸收t1/2 = 3.32小时),但完全吸收。(摘要截断于250字)